Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the implications of the results of his research on further investigation and treatment opportunities for patients with polycythemia vera.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the noteworthy results observed in the study in relation to cause of death among patients with polycythemia vera.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the issues existing around prior data on the causes of death for patients with polycythemia vera (PV) and why it was important to have greater clarity in this area.
Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on how airway obstruction and respiratory distress can impact pediatric patients versus adult patients.
Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on what the treatment options are for patients with congenital plasminogen deficiency with airway obstruction and respiratory distress.
Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on what FTX-6058 is, how it was developed, and what it is able to treat.
Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on how maintaining expression of the anti-sickling gamma ortholog could be beneficial for children and adults with sickle cell disease, and why this is important to investigate.
Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on the common manifestations of congenital plasminogen deficiency, and whether it is life threatening for patients.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the common treatments for patients with polycythemia vera.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the survival estimates for patients with polycythemia vera in the past and the mortality rates among these patients.
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.
Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on what sickle cell disease and beta-thalassemias are caused by, and how hemoglobin gamma can prevent or reduce disease-related pathophysiology in these disorders.
Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about the importance of preparing pharmacists and students to vaccinate the general public with the COVID-19 vaccine.
In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.
Pharmacy Times® interviewed Chad Landmon, JD, of Axinn, Veltrop & Harkrider, on the arguments presented to the Supreme Court on whether a legislative change to the Affordable Care Act makes the law unconstitutional.
In an interview with Pharmacy Times, Peter Bonis, MD, said pharmacists are instrumental in making sure that patients receive drugs that are both safe and effective.
Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about preparation for the possibility of a general public COVID-19 vaccine.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on the economic impact of the COVID-19 pandemic on small businesses, such as community pharmacies.
In a discussion with Pharmacy Times, Susan DiGregorio, BS Pharm, MS, RPh, director of clinical pharmacy development at Community Care Rx, said that collaborating with pediatricians and other health care providers is essential for pharmacists to effectively administer vaccines to children.
Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.
